Mona Alfaraj: Therapeutic Apheresis Case Series in Sickle Cell Disease with Fat Embolism Syndrome
Mona Alfaraj, Consultant Hematopathologist and Transfusionist, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Hemoglobin:
“Happy to share that one of our works on therapeutic apheresis has been published. Grateful for the collaboration and the opportunity to contribute in a scientific work that supports better patient care. Proud of the team and the journey behind this work.
For those with trasfusion and apheresis interest, it is worth to emphasize that although plasma is the standard replacement fluid in TPE for FES, a 50:50 replacement protocol using FFP and 5% human albumin was used in both reported cases. This approach aligns with ASFA guidelines , which recommend limiting full FFP replacement to conditions with clear coagulopathy or high bleeding risk.
In sickle cell disease, this mixed replacement strategy aims to reduce donor plasma exposure while ensuring that the FFP provided is sufficient to address any preexisting or exchange-induced coagulopathy.
A similar protocol has been used in other studies involving critically ill patients with sickle cell disease and multi organ failure.
This case series is a step of greater project of optimum utilization of plasma in therapeutic plasma exchange .”
Title: Therapeutic Plasma Exchange as a Rescue Therapy in Sickle Cell Disease-Associated Fat Embolism Syndrome: Case Series and Literature Review
Authors: Abdulmohsen K. Aljishia, Fatimah A. Alrabia, Abdullah M. Al Abbas, Mona M. Alfaraji, Fadhel A. Alomard, Salah Abohelaikac
Read the Full Article on Hemoglobin
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Feb 8, 2026, 14:27Sandra Revill Tremulis: The Major Trial Testing Whether Lp(a) Lowering Saves Lives
-
Feb 8, 2026, 14:09Mashukur Rahman: New ESC Dyslipidemia Updates Expand the Role of Statins
-
Feb 8, 2026, 13:58Alan Nurden: A “Gold Medal” Study on Silk Fibroin 3D Models for Bone Marrow Fibrosis
-
Feb 8, 2026, 13:45Shinya Goto։ New Lancet Meta-Analysis on Statin-Related Adverse Effects
-
Feb 8, 2026, 13:29Andrea Marshall: Highlighting the Impact of PBM Conference 2026 on Patient-Centred Blood Care
-
Feb 8, 2026, 13:12OncoDaily’s Managing Editor Elen Baloyan Releases Her First Mini-EP
-
Feb 8, 2026, 12:57Shiny K. Kajal: A Hidden Cause of Persistent Mild Anemia
-
Feb 8, 2026, 12:54Gokul Patil Receives AHA Funding to Investigate Thrombo-Inflammatory Mechanisms Underlying Long COVID
-
Feb 7, 2026, 17:00Heghine Khachatryan: Despite Progress, Many People with Hemophilia Remain Undiagnosed Worldwide